RBC Capital Maintains Outperform on Globus Medical, Lowers Price Target to $115

Benzinga Newsdesk www.benzinga.com Negative 94.4%

Neg 94.4% Neu 0% Pos 0%

RBC Capital analyst Shagun Singh maintains Globus Medical (NYSE:GMED) with a Outperform and lowers the price target from $120 to $115.